Akebia Therapeutics Inc (NASDAQ: AKBA) open the trading on Wednesday, with a bit cautious approach as it glided -5.88% to $1.76, before settling in for
On Friday, Akebia Therapeutics Inc (NASDAQ: AKBA) was 1.65% up from the session before settling in for the closing price of $1.82. A 52-week range
On Tuesday, Akebia Therapeutics Inc (NASDAQ: AKBA) was -2.94% drop from the session before settling in for the closing price of $2.04. A 52-week range
Witnessing the stock’s movement on the chart, on Wednesday, Akebia Therapeutics Inc (NASDAQ: AKBA) had a quiet start as it plunged -0.49% to $2.03, before
On Friday, Akebia Therapeutics Inc (NASDAQ: AKBA) was unchanged from the session before settling in for the closing price of $2.06. A 52-week range for
On Friday, Akebia Therapeutics Inc (NASDAQ: AKBA) was 3.30% up from the session before settling in for the closing price of $1.82. A 52-week range
Akebia Therapeutics Inc (NASDAQ: AKBA) started the day on Wednesday, with a price decrease of -1.65% at $1.79, before settling in for the price of
On Friday, Akebia Therapeutics Inc (NASDAQ: AKBA) was -3.76% drop from the session before settling in for the closing price of $1.86. A 52-week range
Akebia Therapeutics Inc (NASDAQ: AKBA) started the day on Thursday, with a price decrease of -6.75% at $1.87, before settling in for the price of
On Monday, Akebia Therapeutics Inc (NASDAQ: AKBA) opened higher 9.47% from the last session, before settling in for the closing price of $1.69. Price fluctuations
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
